1/ The future of #CANCER THERAPEUTICS is looking brighter than ever with innovative treatments like CAR-T, which involves engineering a patient's immune cells to target and destroy cancer.
A thread highlighting the emerging therapeutic platforms we are most excited about 👇
2/ Another exciting development is the use of IMMUNE CHECKPOINTS, which can help boost the immune response against cancer by blocking proteins that prevent the immune system from attacking cancer cells.
3/ CD3 BI-FUNCTIONAL ANTIBODIES are also a promising area of research, these drugs can target both cancer cells and T-cells, which can help enhance the immune response against cancer.
4/ ADCs, or antibody-drug conjugates, are another exciting area of cancer therapeutics, which involves using antibodies to deliver targeted chemotherapy drugs directly to cancer cells.
5/ Synthetic lethality and DNA Damage Response (DDR), are also important areas of cancer research, as they involve targeting the underlying mechanisms that allow cancer cells to survive and grow.
6/ OFF THE SHELF CAR-T and TCR-T treatments, both ex-vivo and in-vivo, are also showing promise, as they involve engineering T-cells to recognize and attack cancer cells by targeting specific proteins on the surface of cancer cells.
7/ Degraders are another innovative approach to cancer therapy, which involves using small molecules to target and degrade specific proteins that are essential for cancer cell survival.
8/ Cancer vaccines are also a promising area of research, as they involve training the immune system to recognize and attack cancer cells, much like a traditional vaccine trains the immune system to recognize and attack a virus.
9/ Myeloid checkpoints are also an exciting area of cancer research, as they involve targeting specific immune cells in the tumor microenvironment that can promote cancer growth and survival.